## Abstract The synthesis is described of the protected linear decapeptide: __N__‐benzyloxycarbonyl‐__S__‐benzyl‐__L__‐cysteinyl‐__L__‐tyrosyl‐__L__‐tyrosyl‐__L__‐phenylalanyl‐__L__‐glutaminyl‐__L__‐asparaginyl‐__S__‐benzyl‐__L__‐cysteinyl‐__L__‐prolyl‐__L__‐leucylglycineamide (III, Fig. 2). Remov
Synthesis of a tyrosine “homologue” of oxytocin
✍ Scribed by H. C. Beyerman; J. S. Bontekoe; A. C. Koch
- Book ID
- 104586134
- Publisher
- Elsevier Science
- Year
- 2010
- Tongue
- English
- Weight
- 354 KB
- Volume
- 79
- Category
- Article
- ISSN
- 0165-0513
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
A synthesis is described of the “protected” decapeptide N‐benzyloxycarbonyl‐S‐benzyl‐L‐cysteinyl‐L‐tyrosyl‐L‐tyrosyl‐L‐isoleucyl‐L‐glutaminyl‐L‐asparaginyl‐S‐benzyl‐L‐cysteinyl‐L‐prolyl‐L‐leucylglycineamide (V).
Removal of the blocking groups from V followed by oxidation yielded biologically active preparations believed to contain a “homologue” of oxytocin with two consecutive molecules of tyrosine instead of one (VI). Oxytocin‐inhibiting activities of VI have been described by other investigators.
📜 SIMILAR VOLUMES
## Abstract The synthesis is described of the protected linear decapeptide: __N__‐benzyloxycarbonyl‐__S__‐benzyl‐__L__‐cysteinyl‐__L__‐tyrosyl‐__L__‐tyrosyl‐__L__‐phenylalanyl‐__L__‐glutaminyl‐__L__‐asparaginyl‐__S__‐benzyl‐__L__‐cysteinyl‐__L__‐prolyl‐__N__^6^‐tosyl‐__L__‐lysylglycineamide (II, Fi
## Abstract The synthesis is described of the protected linear decapeptide: __N__‐benzyloxycarbonyl‐__S__‐benzyl‐__L__‐cysteinyl‐__L__‐tyrosyl‐__L__‐tyrosyl‐__L__‐isoleucyl‐__L__‐glutaminyl‐__L__‐asparaginyl‐__S__‐benzyl‐__L__‐cysteinyl‐__L__‐prolyl‐__N__^e^‐tosyl‐__L__‐lysylglycineamide (II, Fig.